MedPath

ong-term follow-up after restrictive mitral annuloplasty for functional mitral regurgitation.

Conditions
Mitral regurgitation
10046973
10007593
Registration Number
NL-OMON42573
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Patients who have undergone a restrictive mitral annuloplasty between the years 2000 and 2014 at the LUMC.

Exclusion Criteria

Patients in whom the restrictive annuloplasty ring has been explanted.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Cardiac mortality.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- All-cause mortality<br /><br>- Valve-related mortality<br /><br>- Hospital readmissions for heart failure and other cardiovascular causes<br /><br>- Major adverse valve-related events<br /><br>- Echocardiographic outcome (atrial and ventricular dimensions, volumes and<br /><br>function; mitral and tricuspid regurgitation, effective orifice area and<br /><br>transvalvular gradients)<br /><br>- Functional outcome (6-minute walk test, NYHA, CCS)<br /><br>- Quality of life (SF-36 questionnaire, Minnesota Living with Heart Failure<br /><br>Questionnaire)</p><br>
© Copyright 2025. All Rights Reserved by MedPath